COLLEGE PARK, Maryland (Reuters) - Boston Scientific Corp on Thursday moved closer to winning U.S. clearance to promote implanted cardiac devices for patients in earlier stages of heart failure. A government advisory panel unanimously urged approval of the company's Cardiac Resynchronization Therapy Defibrillators, or CRT-Ds, for patients with heart failure who have no symptoms or only mild symptoms. The ...

WASHINGTON (Reuters) - U.S. health officials on Thursday sought to clamp down on the marketing of cigarettes to children and teenagers, issuing national limits on merchandise sales, event sponsorships and other promotions after a failed attempt more than a decade ago. Under the U.S. Food and Drug Administration rules, tobacco companies such as Reynolds American Inc and Altria Group ...

WASHINGTON (Reuters) - U.S. regulators, drug companies, philanthropists and advocates announced a new alliance on Thursday to speed tuberculosis drugs to market, a day after cancer researchers and drugmakers launched a similar initiative. The U.S. Food and Drug Administration said it will work with drug developers to help them through some of the requirements for testing drugs before they ...

Federal health advisers said Thursday an electronic heart implant should be approved for a large group of heart-disease patients who currently aren't eligible for the device. A Food and Drug Administration panel of cardiologists voted unanimously in favor of Boston Scientific's heart-regulating device to treat ...